AI Tool Detects 6 Heart Conditions From Simple EKG Scans

A simple heart scan just got a whole lot smarter, and it could save countless lives.

Researchers at New York-Presbyterian Hospital and Columbia University have developed EchoNext, an artificial intelligence tool that can detect six different forms of structural heart disease from a standard electrocardiogram. The FDA gave the technology sweeping approval this month.

The breakthrough addresses a real challenge in medicine. Structural heart disease includes conditions where blood can't flow properly through blocked or leaky valves, or when the heart's chambers don't pump blood effectively. These problems often require more complex tests to diagnose.

Now doctors can upload an EKG image and get an instant algorithmic prediction. The technology is being commercialized by Pathway Labs, a spinout company from the research team.

What makes this especially exciting is how quickly it will reach doctors. Pathway Labs is licensing the technology to OpenEvidence, a medical evidence search engine that hundreds of thousands of clinicians already use every day. That means widespread access without requiring hospitals to overhaul their systems.

The move represents a novel approach to deploying medical AI. Instead of just marketing to individual hospitals, Pathway is embedding the tool into a platform doctors already trust and use regularly.

The Ripple Effect

This approval signals a shift in how AI can support frontline medicine. EKGs are one of the most common diagnostic tests performed worldwide. They're quick, non-invasive, and relatively inexpensive.

By making these routine scans more powerful, doctors in smaller clinics and rural hospitals gain access to insights that previously required specialized equipment or referrals to heart specialists. That could mean earlier interventions and better outcomes for patients who might otherwise slip through the cracks.

The technology also frees up cardiologists to focus on complex cases while primary care doctors get AI-powered support for initial screenings. It's the kind of practical application of artificial intelligence that can improve care without replacing the human element of medicine.

Early detection of heart disease remains one of the most important factors in successful treatment, and this tool puts that capability into more hands than ever before.